US & European Markets for Cartilage Repair 2011-2021

News provided by

Research and Markets

13 Oct, 2015, 15:10 GMT

DUBLIN, Oct. 8, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/cntk74/us_and_european) has announced the addition of the "US & European Markets for Cartilage Repair - 16 Countries (2010-2021)" report to their offering.

Continue Reading
This image opens in the lightbox
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

Articular cartilage is a connective tissue that lines the ends of bones in joints. It provides shock absorption within the joint and prevents abrasion from occurring to the articular surfaces of bone. Cartilage, in its various forms, is found in intervertebral discs, as the articular lining for joint surfaces and in the meniscal pads of the knees. All types of this tissue are poorly vascularized and, as proper healing requires adequate blood flow, cartilage is one of the slowest healing tissues of the body. Osteoarthritis is cumulative trauma that eventually wears away at cartilaginous surfaces, exposing the underlying bone to additional wear. There are few alternatives to osteobiologic cartilage repair. Damage to cartilage is difficult to treat because the tissue lacks blood supply and has limited capacity for self repair.

The use of cartilage repair products or allografts only accounted for just over 5% of all cartilage repair procedures in 2014. The efficacy of a cartilage repair technique is always compared to the success of a microfracture procedure, which provides reasonable relief and is inexpensive to perform. A cartilage repair implant, which is likely to feature a high price to cover development costs, must justify the premium pricing with sufficiently superior results. This price premium is why most cartilage repair segments are growing at a slow rate.

Key Topics Covered:

  1. Research Methodology
  2. European Country Profiles
  3. Cartilage Repair Overview
  4. European Cartilage Repair Market
  5. U.S. Cartilage Repair Market

Companies Mentioned

  • TiGenix
  • Genzyme
  • TETEC
  • Anika
  • Arthrex
  • DePuy Mitek
  • Co. Don
  • ConMed Linvatec
  • Covidien
  • Vericel
  • Zimmer
  • MTF
  • RTI Surgical
  • Osiris Therapeutics
  • Vivex Biomedical

For more information visit http://www.researchandmarkets.com/research/cntk74/us_and_european

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com